Jump to content
RemedySpot.com

- Amarillo Biosciences, Inc. Licenses Rights to Low Dose Oral Interferon

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 02

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Amarillo Biosciences, Inc. Licenses Rights to Low Dose Oral Interferon For

Hepatitis B in 40 African Countries; and Executes Dietary Supplement Agreement

For Korea

AMARILLO, Texas, July 15 /PRNewswire-FirstCall/ -- Amarillo Biosciences, Inc.

(OTC Bulletin Board: AMAR - News) announces the Company has signed a licensing

agreement with African Health Solutions, LLC, Greenville, Delaware providing the

rights to oral low-dose interferon alpha for the treatment of hepatitis B

patients in Africa.

http://biz./prnews/020715/dam033_1.html

Link to comment
Share on other sites
Guest guest

Guest guest

Posted
Posted

Amarillo Biosciences, Inc. Licenses Rights to Low Dose Oral Interferon For

Hepatitis B in 40 African Countries; and Executes Dietary Supplement Agreement

For Korea

AMARILLO, Texas, July 15 /PRNewswire-FirstCall/ -- Amarillo Biosciences, Inc.

(OTC Bulletin Board: AMAR - News) announces the Company has signed a licensing

agreement with African Health Solutions, LLC, Greenville, Delaware providing the

rights to oral low-dose interferon alpha for the treatment of hepatitis B

patients in Africa.

http://biz./prnews/020715/dam033_1.html

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...